Present status of biological response modifiers in cancer
- 29 December 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 99 (6) , 54s-56s
- https://doi.org/10.1016/s0002-9343(99)80288-5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2JNCI Journal of the National Cancer Institute, 1994
- Angiogenesis and breast cancer.Journal of Clinical Oncology, 1994
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B?-hemolytic streptococcusZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patientsJournal of Clinical Immunology, 1988
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985